Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  HIV Infection

  Free Subscription


1 BMC Cancer
2 Cancer
2 Clin Infect Dis
2 HIV Med
1 Int J Cancer
1 Int J Dermatol
11 J Acquir Immune Defic Syndr
2 J Infect Dis
4 Lancet
5 Nat Med
1 Pediatr Infect Dis J
7 PLoS One
1 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. SILVERBERG MJ, Pimentel N, Leyden WA, Leong TK, et al
    Initial antiretroviral therapy regimen and risk of heart failure.
    AIDS. 2023 Nov 14. doi: 10.1097/QAD.0000000000003786.
    PubMed         Abstract available

  2. CHERKOS AS, LaCourse SM, Kinuthia J, Mecha J, et al
    Maternal breastfeeding and education impact infant growth and development more than in utero HIV/ART exposure in context of universal ART: a prospective study.
    AIDS. 2023 Nov 14. doi: 10.1097/QAD.0000000000003785.
    PubMed         Abstract available

  3. POWIS KM, Moschen G, Jexler J, Ronan A, et al
    Who is championing programming to ensure children who are HIV-exposed yet uninfected thrive to their fullest potential?
    AIDS. 2023;37:2433-2434.

  4. LASMANOVICH R, Atias D, Mor O, Obolski U, et al
    False-positive HIV screening tests during the COVID-19 pandemic, a passing trend?
    AIDS. 2023;37:2430-2432.
    PubMed         Abstract available

  5. CLEMENTE T, Lolatto R, Papaioannu Borjesson R, Fabbiani M, et al
    Sexually transmitted infections in people with multidrug-resistant HIV.
    AIDS. 2023;37:2425-2430.
    PubMed         Abstract available

  6. SMITH-SREEN J, Bosire R, Farquhar C, Katz DA, et al
    Leveraging emergency care to reach key populations for 'the last mile' in HIV programming: a waiting opportunity.
    AIDS. 2023;37:2421-2424.

    Predicting acute kidney injury: do we need biomarkers?
    AIDS. 2023;37:2419-2420.

  8. O'SHEA JG, Cholli P, Heil EL, Buchacz K, et al
    Considerations for long-acting antiretroviral therapy in older persons with HIV.
    AIDS. 2023;37:2271-2286.
    PubMed         Abstract available

    BMC Cancer

  9. MWALIKO E, Itsura P, Keter A, De Bacquer D, et al
    Survival of cervical cancer patients at Moi teaching and Referral Hospital, Eldoret in western Kenya.
    BMC Cancer. 2023;23:1104.
    PubMed         Abstract available


  10. NOOKA AK, Rodriguez C, Mateos MV, Manier S, et al
    Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC-1 study.
    Cancer. 2023 Nov 14. doi: 10.1002/cncr.35107.
    PubMed         Abstract available

  11. RAJDEV L, Jackie Wang CC, Joshi H, Lensing S, et al
    Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study.
    Cancer. 2023 Nov 14. doi: 10.1002/cncr.35110.
    PubMed         Abstract available

    Clin Infect Dis

  12. SPINELLI MA, Christopoulos KA, Moreira CV, Jain JP, et al
    Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2023 Nov 14:ciad657. doi: 10.1093.
    PubMed         Abstract available

  13. MINTER DJ, Appa A, Chambers HF, Doernberg SB, et al
    Contemporary Management of Staphylococcus aureus Bacteremia-Controversies in Clinical Practice.
    Clin Infect Dis. 2023 Nov 10:ciad500. doi: 10.1093.
    PubMed         Abstract available

    HIV Med

  14. VAN HALSEMA CL, Eades CP, Johnston VJ, Miller RF, et al
    British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical investigation and management of pyrexia of unknown origin 2023.
    HIV Med. 2023;24 Suppl 4:3-18.

  15. CELIK D, van Bremen K, Breitschwerdt S, Elamouri F, et al
    Hepatitis delta in HIV/hepatitis B coinfection: A call for action.
    HIV Med. 2023 Nov 15. doi: 10.1111/hiv.13581.

    Int J Cancer

  16. TULSIDAS S, Fontes F, Monteiro K, Mussa M, et al
    Cervical cancer in Mozambique: Clinical characteristics, treatment and survival of incident cases admitted to the Oncology Service of Maputo Central Hospital in 2016-2018.
    Int J Cancer. 2023 Nov 14. doi: 10.1002/ijc.34779.
    PubMed         Abstract available

    Int J Dermatol

  17. NYASULU PS, Tamuzi JL
    Epidemiology, clinical profiles, and prognostic value of COVID-19-related cutaneous manifestations in African populations: a rapid narrative review.
    Int J Dermatol. 2023 Nov 15. doi: 10.1111/ijd.16872.
    PubMed         Abstract available

    J Acquir Immune Defic Syndr

  18. JACKSON H, Dunphy C, Grist MB, Jiang X, et al
    Weathering the Storm: Syringe Services Program Laws and Human Immunodeficiency Virus During the COVID-19 Pandemic.
    J Acquir Immune Defic Syndr. 2023;94:395-402.
    PubMed         Abstract available

  19. WIEHE SE, Nelson TL, Aalsma MC, Rosenman MB, et al
    HIV Care Continuum Among People Living With HIV and History of Arrest and Mental Health Diagnosis.
    J Acquir Immune Defic Syndr. 2023;94:403-411.
    PubMed         Abstract available

  20. FAIRLIE L, Sawry S, Pals S, Sherman G, et al
    More Frequent HIV Viral Load Testing With Point-Of-Care Tests Detects Elevated Viral Load Earlier in Postpartum HIV-Positive Women in a Randomized Controlled Trial in Two Clinics in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2023;94:412-420.
    PubMed         Abstract available

  21. JOHNSON AL, Butts SA, Rodriguez E, Craker L, et al
    "Test-To-PrEP": Assessing Reach and Adoption of a New Approach to Increase HIV Testing and PrEP Knowledge Using HIV Self-Test Kit Distribution Through PrEP Clients' Social Networks.
    J Acquir Immune Defic Syndr. 2023;94:421-428.
    PubMed         Abstract available

  22. HUMPHREY J, Wanjama E, Carlucci JG, Naanyu V, et al
    Preferences of Pregnant and Postpartum Women for Differentiated Service Delivery in Kenya.
    J Acquir Immune Defic Syndr. 2023;94:429-436.
    PubMed         Abstract available

  23. O'HALLORAN JA, Parra-Rodriguez L, Goss CW, Agarwal M, et al
    Impact of Integrase Strand Transfer Inhibitors on Cognition in the HAILO Cohort.
    J Acquir Immune Defic Syndr. 2023;94:437-444.
    PubMed         Abstract available

  24. MOTTA F, Milic J, Gozzi L, Belli M, et al
    A Machine Learning Approach to Predict Weight Change in ART-Experienced People Living With HIV.
    J Acquir Immune Defic Syndr. 2023;94:474-481.
    PubMed         Abstract available

  25. KHOURI A, Stephens MJ, Young J, Galyean P, et al
    Cancer Treatment Decision-Making for People Living With HIV: Physician-Reported Barriers, Facilitators, and Recommendations.
    J Acquir Immune Defic Syndr. 2023;94:482-489.
    PubMed         Abstract available

  26. BROOKS KM, Pau AK, Swaim D, Bunn HT, et al
    Pharmacokinetics, Safety, and Tolerability of Once-Daily Darunavir With Cobicistat and Weekly Isoniazid/Rifapentine.
    J Acquir Immune Defic Syndr. 2023;94:468-473.
    PubMed         Abstract available

  27. SWANN SA, King EM, Prior JC, Berger C, et al
    Longitudinal assessment of bone mineral density in women living with and without HIV across reproductive phases.
    J Acquir Immune Defic Syndr. 2023 Nov 9. doi: 10.1097/QAI.0000000000003336.
    PubMed         Abstract available

  28. LANTING VR, Oosterhof P, Moha DA, van Heerde R, et al
    Switching to doravirine in cART experienced patients: An effective and highly tolerated option with substantial cost savings.
    J Acquir Immune Defic Syndr. 2023 Nov 10. doi: 10.1097/QAI.0000000000003337.
    PubMed         Abstract available

    J Infect Dis

  29. ZIVICH PN, Cole SR, Edwards JK, Glidden DV, et al
    HIV prevention among men who have sex with men: tenofovir alafenamide combination preexposure prophylaxis versus placebo.
    J Infect Dis. 2023 Nov 16:jiad507. doi: 10.1093.
    PubMed         Abstract available

  30. PETERS BA, Whalen A, Xue X, Topper EF, et al
    Subclinical atherosclerosis across the menopausal transition in women with and without HIV.
    J Infect Dis. 2023 Nov 8:jiad488. doi: 10.1093.
    PubMed         Abstract available


  31. KASPER T, Yamey G, Dwyer S, McDade KK, et al
    Rethinking how development assistance for health can catalyse progress on primary health care.
    Lancet. 2023 Nov 10:S0140-6736(23)01813-5. doi: 10.1016/S0140-6736(23)01813.
    PubMed         Abstract available

  32. NUNEZ I, Valdes-Ferrer SI
    Classifying necrotising mpox as an AIDS-defining condition - Authors' reply.
    Lancet. 2023;402:1752.

  33. MITJA O, Paredes R, Cabtree B, Orkin C, et al
    Classifying necrotising mpox as an AIDS-defining condition.
    Lancet. 2023;402:1751-1752.

  34. WONG M, Damon IK, Zucker J, Foote MMK, et al
    ART initiation for people living with HIV with severe mpox.
    Lancet. 2023;402:1750.

    Nat Med

  35. SHAHMANESH M, Chimbindi N, Cowan FM
    Person-centered HIV PrEP for cisgender women.
    Nat Med. 2023 Nov 13. doi: 10.1038/s41591-023-02618.

  36. ZHANG L, Iannuzzi S, Chaturvedula A, Irungu E, et al
    Model-based predictions of protective HIV pre-exposure prophylaxis adherence levels in cisgender women.
    Nat Med. 2023 Nov 13. doi: 10.1038/s41591-023-02615.
    PubMed         Abstract available

  37. SCHOMMERS P, Kim DS, Schlotz M, Kreer C, et al
    Dynamics and durability of HIV-1 neutralization are determined by viral replication.
    Nat Med. 2023 Nov 13. doi: 10.1038/s41591-023-02582.
    PubMed         Abstract available

  38. Determining the longevity and dynamics of HIV-1 neutralizing activity.
    Nat Med. 2023 Nov 13. doi: 10.1038/s41591-023-02592.

  39. MOHAMMADI A, Etemad B, Zhang X, Li Y, et al
    Viral and host mediators of non-suppressible HIV-1 viremia.
    Nat Med. 2023 Nov 13. doi: 10.1038/s41591-023-02611.
    PubMed         Abstract available

    Pediatr Infect Dis J

  40. VONASEK BJ, Kumwenda T, Gumulira J, Nyirongo M, et al
    Pediatr Infect Dis J. 2023 Nov 1. doi: 10.1097/INF.0000000000004158.
    PubMed         Abstract available

    PLoS One

  41. MBATIA RJ, Mtisi EL, Ismail A, Henjewele CV, et al
    Interruptions in treatment among adults on anti-retroviral therapy before and after test-and-treat policy in Tanzania.
    PLoS One. 2023;18:e0292740.
    PubMed         Abstract available

  42. NDIMANDE-KHOZA MN, Katz AWK, Moretlwe-Delany S, Travill D, et al
    Family influences on oral PrEP use among adolescent girls and young women in Kenya and South Africa.
    PLoS One. 2023;18:e0292529.
    PubMed         Abstract available

  43. Editorial Note: HIV gp120 Induces Mucus Formation in Human Bronchial Epithelial Cells through CXCR4/alpha7-Nicotinic Acetylcholine Receptors.
    PLoS One. 2023;18:e0294613.

  44. LI C, Xiong Y, Maman S, Matthews DD, et al
    An instant messaging mobile phone application for promoting HIV pre-exposure prophylaxis uptake among Chinese gay, bisexual and other men who have sex with men: A mixed methods feasibility and piloting randomized controlled trial study.
    PLoS One. 2023;18:e0285036.
    PubMed         Abstract available

  45. ALJAHDALY NH, Alharbey RA, Aljohani AS
    Theoretical study of diffusive model of HIV-1 infection and its analytical solution.
    PLoS One. 2023;18:e0283659.
    PubMed         Abstract available

  46. ARIFIN B, Rokhman MR, Zulkarnain Z, Perwitasari DA, et al
    The knowledge mapping of HIV/AIDS in Indonesians living on six major islands using the Indonesian version of the HIV-KQ-18 instrument.
    PLoS One. 2023;18:e0293876.
    PubMed         Abstract available

  47. HARRYPARSAD R, Meyer B, Taku O, Serrano M, et al
    Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptives.
    PLoS One. 2023;18:e0294285.
    PubMed         Abstract available


  48. BORJABAD A, Dong B, Chao W, Volsky DJ, et al
    Innate immune responses reverse HIV cognitive disease in mice: Profile by RNAseq in the brain.
    Virology. 2023;589:109917.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.